-
Mashup Score: 35Program Guide – ASCO Meeting Program Guide - 10 hour(s) ago
Heather Cheng , Sabree Burbage , Carmine Rossi , Ibrahim Khilfeh , Lilian Diaz , Yuxi Wang , Dominic Pilon , Gordon Brown , Neal Shore , Benjamin Lowentritt , Daniel Lin , Mehmet Bilen University of Washington, Johnson & Johnson Innovative Medicine, Analysis Group, Inc., New Jersey Urology, A Summit Health Company, and Rowan University School of Osteopathic Medicine, Carolina Urologic Research Center and Atlantic Urology Clinics, Chesapeake Urology, Winship Cancer Institute of Emory University Janssen
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 32Program Guide – ASCO Meeting Program Guide - 11 hour(s) ago
Umang Swami Department of Medicine, Huntsman Cancer Institute at the University of Utah Umang Swami , Yeonjung Jo , Chadi Hage Chehade , Zeynep Irem Ozay , Nicolas Sayegh , Georges Gebrael , Micah Ostrowski , Patrick Campbell , Siqi HU , Gliceida Galarza Fortuna , Vinay Mathew Thomas , Haoran Li , Ryon Graf , Soumyajit Roy , Benjamin Maughan , Avirup Guha , Irbaz Riaz , Emmanuel Antonarakis , Rana McKay , Neeraj Agarwal Department of Medicine, Huntsman Cancer Institute at the University of Utah, Huntsman
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Ab#95 @ASCO #GU25 by @umangtalking👉https://t.co/1sR9u3eCAw👉In pts w/ mCRPC #prostatecancer in @flatironhealth (n = 14,112)👉43% did not receive a bone-modifying agent👉Need to ⬆️ the use of BMAs in clinical practice👇@Huntsman_GU @OncoAlert @urotoday @PCF_Science https://t.co/pEGwTLo8dg
-
-
Mashup Score: 35Program Guide – ASCO Meeting Program Guide - 15 hour(s) ago
Umang Swami Department of Medicine, Huntsman Cancer Institute at the University of Utah Umang Swami , Yeonjung Jo , Zeynep Irem Ozay , Chadi Hage Chehade , Georges Gebrael , Nicolas Sayegh , Micah Ostrowski , Ethan Anderson , Diya Garg , Ayana Srivastava , Beverly Chigarira , Siqi HU , Vinay Mathew Thomas , Sumati Gupta , Benjamin Maughan , Avirup Guha , Irbaz Riaz , Soumyajit Roy , Neeraj Agarwal Department of Medicine, Huntsman Cancer Institute at the University of Utah, Huntsman Cancer Institute at
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Ab#104 @ASCO #GU25 by @umangtalking👉https://t.co/aeyp68EfiM👉In pts with mHSPC #prostatecancer in @flatironhealth 👉Glad to report an improved utilization of intensified ADT in 77% of pts since January 2023👇@Huntsman_GU @OncoAlert @urotoday @PCF_Science https://t.co/lAJuPnX13Y
-
-
Mashup Score: 43Program Guide – ASCO Meeting Program Guide - 15 hour(s) ago
Nicolas Sayegh , Yeonjung Jo , Umang Swami , Chadi Hage Chehade , Zeynep Irem Ozay , Georges Gebrael , Benjamin Maughan , Melissa Plets , Maha Hussain , Tanya Dorff , Primo Lara Jr., Amir Goldkorn , Seth Lerner , Neeraj Agarwal Huntsman Cancer Institute at the University of Utah, Department of Medicine, Huntsman Cancer Institute at the University of Utah, SWOG Statistic s and Data Management Center, Northwestern University, Feinberg School of Medicine, City of Hope Comprehensive Cancer Center, University
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Ab#173 @ASCO #GU25 by @nsayeghmd 👉https://t.co/EtqWUtpfNQ👉Secondary analysis of the @SWOG 1216 trial: time to metastasis after prostatectomy was not associated with survival in metachronous mHSPC #prostatecancer👇@Huntsman_GU @OncoAlert @urotoday @PCF_Science https://t.co/NEeeLlQHyj
-
-
Mashup Score: 32Program Guide – ASCO Meeting Program Guide - 15 hour(s) ago
Umang Swami Department of Medicine, Huntsman Cancer Institute at the University of Utah Umang Swami , Yeonjung Jo , Chadi Hage Chehade , Zeynep Irem Ozay , Nicolas Sayegh , Georges Gebrael , Micah Ostrowski , Patrick Campbell , Siqi HU , Gliceida Galarza Fortuna , Vinay Mathew Thomas , Haoran Li , Ryon Graf , Soumyajit Roy , Benjamin Maughan , Avirup Guha , Irbaz Riaz , Emmanuel Antonarakis , Rana McKay , Neeraj Agarwal Department of Medicine, Huntsman Cancer Institute at the University of Utah, Huntsman
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Ab#95 @ASCO #GU25 by @umangtalking👉https://t.co/1sR9u3eCAw👉In pts w/ mCRPC #prostatecancer in @flatironhealth (n = 14,112)👉43% did not receive a bone-modifying agent👉Need to ⬆️ the use of BMAs in clinical practice👇@Huntsman_GU @OncoAlert @urotoday @PCF_Science https://t.co/pEGwTLo8dg
-
-
Mashup Score: 16Program Guide – ASCO Meeting Program Guide - 15 hour(s) ago
Pedro Barata , Suvina Amin , Alexander Niyazov , Melissa Kirker , Amanda Ribbands , Jake Butcher , Jacob Skilling , Alex Busby , Alastair Hinds , Elena Castro University Hospitals Seidman Cancer Center, Pfizer Inc., Adelphi Real World, Hospital Universitario 12 de Octubre Homologous recombination repair mutations (HRRms) have predictive/prognostic value in metastatic castration-resistant prostate cancer (mCRPC). While therapies are approved for patients (pts) with HRRm mCRPC, HRRm testing data is limited
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Ab#102 @ASCO #GU25 by @PBarataMD👉https://t.co/FT37nHJ4w6👉In pts w/ mCRPC (n=448) #prostatecancer👉53% received HRRm testing w/ lower testing in pts w/o family history, ⬇️Gleason score & de novo disease👉Need to ⬆️ HRRm testing 👇@Ecastromarcos @OncoAlert @urotoday @PCF_Science https://t.co/tPYZYvEGyQ
-
-
Mashup Score: 41Program Guide – ASCO Meeting Program Guide - 15 hour(s) ago
Arun Azad Department of Medical Oncology, Peter MacCallum Cancer Centre Arun Azad , Marco Badillo , Qiang Dong , Alicia Morgans , Dana Rathkopf , Karie Runcie , Tian Zhang , Geoffrey Gotto , Axel Merseburger , Alex Dos Santos , Sukie Shopeju , Amitabha Bhaumik , Suneel Dinkar Mundle , Sharon McCarthy , Neeraj Ag arwal Department of Medical Oncology, Peter MacCallum Cancer Centre, Hospital Aranda de la Parra, West China Hospital, Sichuan University, Department of Medical Oncology, Dana-Farber Cancer
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Ab#147 @ASCO #GU25 by @AzadOncology👉https://t.co/zi3ow7N2lD👉In the ph3 LIBERTAS trial in pts w/ mHSPC #prostatecancer (n=350)👉ADT+APA led to undetectable PSA in 70.3% of pts & PSA90 response in 87.7% 👉Trial ongoing👇@Huntsman_GU @OncoAlert @urotoday @PCF_Science https://t.co/iYQJqOIZ6y
-
-
Mashup Score: 34Program Guide – ASCO Meeting Program Guide - 15 hour(s) ago
Alan Bryce , Raymond McDermott , Josep Piulats , M. Reaume , Peter Ostler , Joel Gingerich , Elias Pintus , Srikala Sridhar , Richard Bambury , Urban Emmenegger , Henriette Lindberg , David Morris , Franco Nole , John Staffurth , Wassim Abida , Lisa Caunt , Darrin Despain , Charles Ryan , Karim Fizazi , Simon Chowdhury Mayo Clinic in Arizona, St. Vincent’s University Hospital and University College Dublin, Fundacio Institut D’Investigacio Biomedica de Bellvitge, L’Hospitalet del Llobregat, The Ottawa
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Ab#155 @ASCO #GU25 by @AlanBryce9👉https://t.co/m8y7F8nksZ👉In ph3 TRITON3 in pts w/ mCRPC #prostatecancer👉Median OS 22.8 mo w/ rucaparib vs. 21.7 w/ docetaxel/ARPI switch (HR 0.99) (70 pts crossed over to rucaparib)👇@scserendipity1 @OncoAlert @urotoday @PCF_Science https://t.co/JiBuoZMWYW
-
-
Mashup Score: 43Program Guide – ASCO Meeting Program Guide - 15 hour(s) ago
Arun Azad Department of Medical Oncology, Peter MacCallum Cancer Centre Arun Azad , Ding-Wei Ye , Hiroji Uemura , Amitabha Bhaumik , Michael Eisbacher , Anildeep Singh , Sharon McCarthy , Suneel Dinkar Mundle , Kim Chi , Neeraj Agarwal Department of Medical Oncology, Peter MacCallum Cancer Centre, Fudan University Shanghai Cancer Center, Yokohama City University Medical Center, Johnson & Johnson Research and Development, Johnson & Johnson – Australia and New Zealand, Johnson & Johnson, University of
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Ab#165 @ASCO #GU25 by @AzadOncology👉https://t.co/CssaQq8peS👉In ph3 TITAN trial in pts w/ mHSPC #prostatecancer👉rPFS & OS improved w/ ADT+APA regardless of prior CV/metabolic baseline risk or concomitant meds👇@Huntsman_GU @OncoAlert @urotoday @PCF_Science https://t.co/fuHZPGW9Nt
-
-
Mashup Score: 29Program Guide – ASCO Meeting Program Guide - 15 hour(s) ago
Chiara Mercinelli Medical Oncology Department, IRCCS San Raffaele Hospital; Vita-Salute San Raffaele University Chiara Mercinelli , Philippe Spiess , Roger Li , Ashish Kamat , Petros Grivas , Shilpa Gupta , Neeraj Agarwal , Liang Cheng , Dean Pavlick , Ethan Sokol , Ryon Graf , Jeffrey Ross , Alexa Schrock , Julia Quintanilha , Gerald Li , Douglas Lin , Joseph Jacob , Gennady Bratslavsky , Alina Basnet , Andrea Necchi Medical Oncology Department, IRCCS San Raffaele Hospital; Vita-Salute San Raffaele
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Ab#196 @ASCO #GU25 by @CMercinelli👉https://t.co/9bPJfZxH53 👉 Homologous recombination deficiency (HRD) signature found in 11% of pts w/ advanced #prostatecancer & associated w/ unique genomic landscape👇@AndreaNecchi @OncoAlert @urotoday @PCF_Science https://t.co/hKG0opdqr9
-
Ab#77 @ASCO #GU25 by @heatherhcheng 👉 https://t.co/ZI4OtD7RGq👉mHSPC #prostatecancer w/ BRCA1/2 alt had significantly worse TTNT & TTCR than those with no HRR alt 👉Need for early identification & more effective Rx for these pts 👇@bilenma @OncoAlert @urotoday @PCF_Science https://t.co/vcU10JEBJZ